Literature DB >> 17340618

Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.

A M Bleau1, N Planque, N Lazar, D Zambelli, A Ori, T Quan, G Fisher, K Scotlandi, B Perbal.   

Abstract

Previous work had suggested that recombinant CCN3 was partially inhibiting cell proliferation. Here we show that native CCN3 protein secreted into the conditioned medium of glioma transfected cells indeed induces a reduction in cell proliferation. Large amounts of CCN3 are shown to accumulate both cytoplasmically and extracellularly as cells reach high density, therefore highlighting new aspects on how cell growth may be regulated by CCN proteins. Evidence is presented establishing that the amount of CCN3 secreted into cell culture medium is regulated by post-translational proteolysis. As a consequence, the production of CCN3 varies throughout the cell cycle and CCN3 accumulates at the G2/M transition of the cycle. We also show that CCN3-induced inhibition of cell growth can be partially reversed by specific antibodies raised against a C-terminal peptide of CCN3. The use of several clones expressing various portions of CCN3 established that the CT module of CCN3 is sufficient to induce cell growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17340618     DOI: 10.1002/jcb.21262

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  35 in total

Review 1.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 2.  Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  Adv Drug Deliv Rev       Date:  2016-01-04       Impact factor: 15.470

3.  CCN3: Doctor Jekyll and Mister Hyde.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2008-09-12       Impact factor: 5.782

4.  CCN3-mediated promotion of sulfated proteoglycan synthesis in rat chondrocytes from developing joint heads.

Authors:  Danilo Janune; Satoshi Kubota; Noureddine Lazar; Bernard Perbal; Seiji Iida; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2011-05-11       Impact factor: 5.782

5.  Terminology of CCN1-6 should not be applicable for their fragments and be limited to only full length CCN1-6.

Authors:  Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2015-02-20       Impact factor: 5.782

6.  Aortic aneurysm, CCN3 may solve the problem.

Authors:  Yalin Emre; Beat A Imhof
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

7.  CCN proteins: A centralized communication network.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2013-02-19       Impact factor: 5.782

8.  Transforming growth factor β controls CCN3 expression in nucleus pulposus cells of the intervertebral disc.

Authors:  Cassie M Tran; Harvey E Smith; Aviva Symes; Laure Rittié; Bernard Perbal; Irving M Shapiro; Makarand V Risbud
Journal:  Arthritis Rheum       Date:  2011-10

9.  Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization.

Authors:  Wun-Chey Sin; Mimi Tse; Nathalie Planque; Bernard Perbal; Paul D Lampe; Christian C Naus
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

10.  Alternative splicing of CCN mRNAs .... it has been upon us.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2009-04-28       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.